Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 1/20 | 0.33 |
| ▸ | CNR2 | P34972 | 1/20 | 0.33 |
| ▸ | PDE2A | O00408 | 1/20 | 0.32 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15218207 | 0.81 | APP (0.41) | CNR1CNR2PDE2APDE10A | |
| SCHEMBL22822820 | 0.79 | CNR2 (0.37) | CNR1CNR2PDE2APDE10A | |
| SCHEMBL21285478 | 0.77 | SRC (0.36) | CNR1CNR2PDE2APDE10A | |
| SCHEMBL21886203 | 0.77 | CCR1 (0.45) | PDE2APDE10A | |
| SCHEMBL19105580 | 0.74 | OPRM1 (0.39) | CNR1CNR2 | |
| SCHEMBL21783728 | 0.71 | MAP3K5 (0.36) | — | |
| SCHEMBL22039941 | 0.69 | LMNA (0.35) | — | |
| SCHEMBL1618004 | 0.68 | APP (0.39) | PDE2APDE10A | |
| SCHEMBL13706081 | 0.67 | CCR1 (0.52) | PDE2APDE10A | |
| SCHEMBL15341745 | 0.67 | PDE10A (0.34) | CNR1CNR2PDE2APDE10A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230219947-A1 | INHIBITORS OF AV ß6 INTEGRIN | MORPHIC THERAPEUTIC, INC. | 2023-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230219947-A1 | INHIBITORS OF AV ß6 INTEGRIN | ITGB6, ITGA6, GP6 | CNR1 1990/4885CNR2 2526/4885PDE2A 4658/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.